Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL: Partial oral antibiotic treatment for bacterial brain abscess
2019-002845-39Phase 4Active
- Sponsor
- Aalborg University Hospital
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meropenem, ceftriaxone, cefotaxime, metronidazole, amoxicillin and 3 more in brain abscess and bacterial disease (2 arms), sponsored by Aalborg University Hospital. Started Sep 2019; status: active.
02
Drugs
meropenemceftriaxonecefotaximemetronidazoleamoxicillin
03
Conditions
brain abscessbacterial disease
Beyond the preview
Go deeper on 2019-002845-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002845-39.